The FDA has recently approved Valtoco (Diazepam). How is it administered to a patient?
a. Subcutaneously
b. Intramuscularly
c. Orally
d. Rectally
e. Intranasally
Answer: (e). Valtoco (diazepam nasal spray) is indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (ie, seizure clusters, acute repetitive seizures) that are distinct from a patient's usual seizure pattern in patients with epilepsy 6 years of age and older.
Valtoco is a proprietary formulation of diazepam incorporating the Science of Intravail. Intravail transmucosal absorption enhancement technology enables the non-invasive delivery of a broad range of protein, peptide and small molecule drugs.
Try our Naplex QBank. www.pharmacyexam.com **Please note: This type of question will not show up in an MPJE. We are just posting to MPJE group for knowledge.
Ready for the full prep?
Continue your preparation with full NAPLEX practice questions, question bank access, and study materials.
Go to NAPLEX Study Materials